NeuroOne Medical Technologies Corporation — Cash Flow (NASDAQ:NMTC) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities -3.43 M-8.6 M-7.52 M-12.89 M-11.01 M-2.84 M -6.16 M Cash from investing activities -122.43 K-67.08 K-3.24 M2.65 M-120.2 K-81.74 K -98.08 K Cash from financing activities 7.32 M11.53 M12.02 M7.4 M7.27 M8.03 M 8.69 M Free cash flow -3.55 M-8.67 M-7.79 M-13.27 M-11.13 M-2.92 M -6.2 M

뉴스

Best Momentum Stocks to Buy for January 6th

New Strong Buy Stocks for January 6th

신경외과, 페넘브라 임원 제이슨 밀스를 이사회에 임명

NeuroOne appoints Penumbra executive Jason Mills to board

Neuroone Medical Q1 실적, 수익 예상치를 넘어

Neuroone Medical earnings beat, revenue topped estimates

NeuroOne 4분기 실적 급증, 주가 상승

Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises

NeuroOne, 나스닥 상장 유지 위한 기한 연장 승인

NeuroOne Medical Technologies receives Nasdaq extension to regain minimum bid price compliance

신경원, 나스닥 상장 유지 위해 180일 추가 유예 받아

NeuroOne receives 180-day extension to regain nasdaq compliance